Morpholino

MO5-pax6b

ID
ZDB-MRPHLNO-100610-4
Name
MO5-pax6b
Previous Names
  • MO2Pax6b
Target
Sequence
5' - TTGATTTGCACTCACGCTCGGTATG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO5-pax6b
No data available
Phenotype
Phenotype resulting from MO5-pax6b
Phenotype of all Fish created by or utilizing MO5-pax6b
Phenotype Fish Conditions Figures
pancreatic B cell decreased amount, abnormal AB + MO5-pax6b standard conditions Fig. 1,  Fig. 5,  Fig. 6,  Fig. 7,  Fig. S1 from Verbruggen et al., 2010
type B pancreatic cell differentiation disrupted, abnormal AB + MO5-pax6b standard conditions Fig. 1,  Fig. 5,  Fig. S1 from Verbruggen et al., 2010
pancreatic A cell increased amount, abnormal AB + MO5-pax6b standard conditions Fig. 7 from Verbruggen et al., 2010
lens aplastic, abnormal AB + MO5-pax6b standard conditions Fig. 5 from Verbruggen et al., 2010
D cell decreased amount, abnormal AB + MO5-pax6b standard conditions Fig. 1,  Fig. 6,  Fig. 7,  Fig. S1 from Verbruggen et al., 2010
pancreatic A cell decreased amount, abnormal AB + MO5-pax6b standard conditions Fig. 7 from Verbruggen et al., 2010
endocrine pancreas peptide hormone secreting cell increased amount, abnormal AB + MO5-pax6b standard conditions Fig. 1,  Fig. 6,  Fig. 7 from Verbruggen et al., 2010
lens morphogenesis in camera-type eye arrested, abnormal AB + MO5-pax6b standard conditions Fig. 5 from Verbruggen et al., 2010
lens morphogenesis in camera-type eye arrested, abnormal AB + MO5-pax6b + MO8-pax6b standard conditions Fig. 5 from Verbruggen et al., 2010
lens aplastic, abnormal AB + MO5-pax6b + MO8-pax6b standard conditions Fig. 5 from Verbruggen et al., 2010
pancreatic B cell absent, abnormal AB + MO5-pax6b + MO8-pax6b standard conditions Fig. 5,  Fig. 6 from Verbruggen et al., 2010
type B pancreatic cell differentiation disrupted, abnormal AB + MO5-pax6b + MO8-pax6b standard conditions Fig. 5 from Verbruggen et al., 2010
endocrine pancreas peptide hormone secreting cell increased amount, abnormal AB + MO5-pax6b + MO8-pax6b standard conditions Fig. 6 from Verbruggen et al., 2010
D cell decreased amount, abnormal AB + MO5-pax6b + MO8-pax6b standard conditions Fig. 6 from Verbruggen et al., 2010
type B pancreatic cell differentiation disrupted, abnormal m1018Tg; ulg515Tg + MO5-pax6b standard conditions Fig. 3 from Verbruggen et al., 2010
lens decreased size, abnormal m1018Tg; ulg515Tg + MO5-pax6b standard conditions Fig. 3 from Verbruggen et al., 2010
lens morphogenesis in camera-type eye disrupted, abnormal m1018Tg; ulg515Tg + MO5-pax6b standard conditions Fig. 3 from Verbruggen et al., 2010
pancreatic B cell decreased amount, abnormal m1018Tg; ulg515Tg + MO5-pax6b standard conditions Fig. 3 from Verbruggen et al., 2010
post-vent region bent, abnormal TU + MO2-pax6a + MO5-pax6b control Figure 2 with image from Ahmed et al., 2026
post-vent region curved, abnormal TU + MO2-pax6a + MO5-pax6b control Figure 2 with image from Ahmed et al., 2026
iris morphology, abnormal TU + MO2-pax6a + MO5-pax6b control Figure 2 with image from Ahmed et al., 2026
swimming decreased process quality, abnormal TU + MO2-pax6a + MO5-pax6b control Figure 2 with image from Ahmed et al., 2026
eye morphology, abnormal TU + MO2-pax6a + MO5-pax6b control Figure 2 with image from Ahmed et al., 2026
eye decreased size, abnormal TU + MO2-pax6a + MO5-pax6b control Fig. S3,  Figure 2 with image from Ahmed et al., 2026
pericardium edematous, abnormal TU + MO2-pax6a + MO5-pax6b control Figure 2 with image from Ahmed et al., 2026
post-vent region bent, abnormal TU + MO2-pax6a + MO5-pax6b + MO6-wt1a,wt1b control Figure 3 with image from Ahmed et al., 2026
iris morphology, abnormal TU + MO2-pax6a + MO5-pax6b + MO6-wt1a,wt1b control Figure 3 with image from Ahmed et al., 2026
post-vent region curved, abnormal TU + MO2-pax6a + MO5-pax6b + MO6-wt1a,wt1b control Figure 3 with image from Ahmed et al., 2026
swimming decreased process quality, abnormal TU + MO2-pax6a + MO5-pax6b + MO6-wt1a,wt1b control Figure 3 with image from Ahmed et al., 2026
eye morphology, abnormal TU + MO2-pax6a + MO5-pax6b + MO6-wt1a,wt1b control Figure 3 with image from Ahmed et al., 2026
eye decreased size, abnormal TU + MO2-pax6a + MO5-pax6b + MO6-wt1a,wt1b control Figure 3 with image from Ahmed et al., 2026
eye structure, abnormal TU + MO2-pax6a + MO5-pax6b + MO6-wt1a,wt1b control Figure 3 with image from Ahmed et al., 2026
Citations